HEADER HYDROLASE 28-MAY-15 5BPE TITLE CRYSTAL STRUCTURE OF EV71 3CPRO IN COMPLEX WITH A POTENT AND SELECTIVE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: EV71 3CPRO; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HUMAN ENTEROVIRUS TYPE 71; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROVIRUS A71; SOURCE 3 ORGANISM_TAXID: 39054; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEASE, INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.LUQING,Z.YIN REVDAT 4 20-MAR-24 5BPE 1 JRNL REMARK REVDAT 3 20-JAN-16 5BPE 1 JRNL REVDAT 2 09-DEC-15 5BPE 1 JRNL REVDAT 1 25-NOV-15 5BPE 0 JRNL AUTH Y.ZHAI,X.ZHAO,Z.CUI,M.WANG,Y.WANG,L.LI,Q.SUN,X.YANG,D.ZENG, JRNL AUTH 2 Y.LIU,Y.SUN,Z.LOU,L.SHANG,Z.YIN JRNL TITL CYANOHYDRIN AS AN ANCHORING GROUP FOR POTENT AND SELECTIVE JRNL TITL 2 INHIBITORS OF ENTEROVIRUS 71 3C PROTEASE JRNL REF J.MED.CHEM. V. 58 9414 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26571192 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01013 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.21 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.780 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.0 REMARK 3 NUMBER OF REFLECTIONS : 4147 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 199 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.2126 - 2.6904 0.89 3948 199 0.1625 0.2814 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.470 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 1464 REMARK 3 ANGLE : 1.193 1971 REMARK 3 CHIRALITY : 0.048 215 REMARK 3 PLANARITY : 0.004 254 REMARK 3 DIHEDRAL : 17.308 545 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 1 THROUGH 180) REMARK 3 ORIGIN FOR THE GROUP (A): 13.3421 0.1040 15.9770 REMARK 3 T TENSOR REMARK 3 T11: 0.2098 T22: 0.1876 REMARK 3 T33: 0.2046 T12: -0.0053 REMARK 3 T13: -0.0076 T23: -0.0097 REMARK 3 L TENSOR REMARK 3 L11: 1.6312 L22: 1.6969 REMARK 3 L33: 1.2592 L12: 0.1032 REMARK 3 L13: -0.1573 L23: -0.4607 REMARK 3 S TENSOR REMARK 3 S11: 0.1486 S12: 0.0048 S13: 0.0263 REMARK 3 S21: 0.1202 S22: -0.0528 S23: 0.0106 REMARK 3 S31: 0.0230 S32: -0.1325 S33: -0.0846 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 301 THROUGH 313) REMARK 3 ORIGIN FOR THE GROUP (A): 8.1889 -1.0294 20.3601 REMARK 3 T TENSOR REMARK 3 T11: 0.0329 T22: 0.1227 REMARK 3 T33: 0.1800 T12: -0.0195 REMARK 3 T13: 0.0781 T23: 0.0000 REMARK 3 L TENSOR REMARK 3 L11: 0.2620 L22: 0.0451 REMARK 3 L33: 0.0785 L12: 0.0419 REMARK 3 L13: -0.0297 L23: 0.0348 REMARK 3 S TENSOR REMARK 3 S11: 0.0412 S12: -0.0682 S13: 0.1303 REMARK 3 S21: 0.0213 S22: -0.0351 S23: 0.0045 REMARK 3 S31: -0.0297 S32: -0.0609 S33: -0.1064 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5BPE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-JUN-15. REMARK 100 THE DEPOSITION ID IS D_1000210318. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JAN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4147 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.9 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS-HCL (PH 7.7), 200MM SODIUM REMARK 280 CITRATE AND 20% POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 38.38300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.63550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 38.38300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 31.63550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 59.18741 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 34.54462 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 313 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 65 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU A 24 O HOH A 301 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 THR A 142 O - C - N ANGL. DEV. = -10.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 32 -123.36 48.61 REMARK 500 LYS A 42 60.23 38.60 REMARK 500 ASP A 51 16.88 59.83 REMARK 500 ASP A 64 177.66 -40.05 REMARK 500 THR A 142 -169.95 -51.04 REMARK 500 THR A 154 98.60 -61.97 REMARK 500 ARG A 167 -44.46 -133.15 REMARK 500 PHE A 179 53.28 -141.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 THR A 142 -10.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE ENZYME INHIBITOR REMARK 630 MOLECULE NAME: (2~{S})-~{N}-[(1~{R},2~{S})-1-CYANO-1-OXIDANYL-3- REMARK 630 [(3~{S})-2-OXIDANYLIDENEPIPERIDIN-3-YL]PROPAN-2-YL]-3-PHENYL-2-[[(~ REMARK 630 {E})-3-PHENYLPROP-2-ENOYL]AMINO]PROPANAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 E22 A 201 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: TCA PHE 4UG REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E22 A 201 DBREF 5BPE A 1 180 PDB 5BPE 5BPE 1 180 SEQRES 1 A 180 GLY PRO ALA PHE GLU PHE ALA VAL ALA MET MET LYS ARG SEQRES 2 A 180 ASN SER SER THR VAL LYS THR GLU TYR GLY GLU PHE THR SEQRES 3 A 180 MET LEU GLY ILE TYR ASP ARG TRP ALA VAL LEU PRO ARG SEQRES 4 A 180 HIS SER LYS PRO GLY PRO THR ILE LEU MET ASN ASP GLN SEQRES 5 A 180 GLU VAL GLY VAL LEU ASP ALA LYS GLU LEU VAL ASP LYS SEQRES 6 A 180 ASP GLY THR ASN LEU GLU LEU THR LEU LEU LYS LEU ASN SEQRES 7 A 180 ARG ASN GLU LYS PHE ARG ASP ILE ARG GLY PHE LEU ALA SEQRES 8 A 180 LYS GLU GLU VAL GLU VAL ASN GLU ALA VAL LEU ALA ILE SEQRES 9 A 180 ASN THR SER LYS PHE PRO ASN MET TYR ILE PRO VAL GLY SEQRES 10 A 180 GLN VAL THR GLU TYR GLY PHE LEU ASN LEU SER GLY LYS SEQRES 11 A 180 PRO THR LYS ARG MET LEU MET TYR ASN PHE PRO THR LYS SEQRES 12 A 180 ALA GLY GLN CYS GLY GLY VAL LEU MET SER THR GLY LYS SEQRES 13 A 180 VAL LEU GLY ILE HIS ILE GLY GLY ASN GLY ARG GLN GLY SEQRES 14 A 180 PHE SER ALA ALA LEU LEU LYS HIS TYR PHE ASN HET E22 A 201 35 HETNAM E22 (2~{S})-~{N}-[(1~{R},2~{S})-1-CYANO-1-OXIDANYL-3- HETNAM 2 E22 [(3~{S})-2-OXIDANYLIDENEPIPERIDIN-3-YL]PROPAN-2-YL]-3- HETNAM 3 E22 PHENYL-2-[[(~{E})-3-PHENYLPROP-2- HETNAM 4 E22 ENOYL]AMINO]PROPANAMIDE FORMUL 2 E22 C27 H30 N4 O4 FORMUL 3 HOH *13(H2 O) HELIX 1 AA1 GLY A 1 ASN A 14 1 14 HELIX 2 AA2 HIS A 40 LYS A 42 5 3 HELIX 3 AA3 ASP A 85 LEU A 90 5 6 HELIX 4 AA4 LEU A 175 ASN A 180 5 6 SHEET 1 AA1 7 SER A 15 THR A 20 0 SHEET 2 AA1 7 GLY A 23 TYR A 31 -1 O PHE A 25 N VAL A 18 SHEET 3 AA1 7 TRP A 34 PRO A 38 -1 O TRP A 34 N TYR A 31 SHEET 4 AA1 7 ASN A 69 LEU A 77 -1 O LEU A 75 N ALA A 35 SHEET 5 AA1 7 GLN A 52 VAL A 63 -1 N LEU A 62 O LEU A 72 SHEET 6 AA1 7 THR A 46 MET A 49 -1 N MET A 49 O GLN A 52 SHEET 7 AA1 7 SER A 15 THR A 20 -1 N LYS A 19 O LEU A 48 SHEET 1 AA2 7 VAL A 97 ILE A 104 0 SHEET 2 AA2 7 MET A 112 LEU A 127 -1 O ILE A 114 N LEU A 102 SHEET 3 AA2 7 LYS A 130 TYR A 138 -1 O THR A 132 N LEU A 125 SHEET 4 AA2 7 GLY A 169 ALA A 173 -1 O GLY A 169 N TYR A 138 SHEET 5 AA2 7 LYS A 156 GLY A 164 -1 N ILE A 160 O ALA A 172 SHEET 6 AA2 7 VAL A 150 SER A 153 -1 N LEU A 151 O LEU A 158 SHEET 7 AA2 7 VAL A 97 ILE A 104 -1 N VAL A 101 O MET A 152 CISPEP 1 ALA A 144 GLY A 145 0 -5.19 CISPEP 2 CYS A 147 GLY A 148 0 -7.23 SITE 1 AC1 17 HIS A 40 GLU A 71 ASN A 126 LEU A 127 SITE 2 AC1 17 SER A 128 LYS A 130 THR A 142 LYS A 143 SITE 3 AC1 17 ALA A 144 GLY A 145 GLN A 146 CYS A 147 SITE 4 AC1 17 HIS A 161 ILE A 162 GLY A 163 GLY A 164 SITE 5 AC1 17 HOH A 301 CRYST1 76.766 63.271 38.760 90.00 116.97 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013027 0.000000 0.006628 0.00000 SCALE2 0.000000 0.015805 0.000000 0.00000 SCALE3 0.000000 0.000000 0.028947 0.00000